Pfizer's and Moderna's formulas have been the go-to on pharmacy shelves, but Novavax remains an important option.

Now, let's get back to our question. Is the stock a buy or a sell? This depends a lot on your own particular investment ...

NACI added that anyone above 6 months of age who isn't considered high risk "may receive the most recently updated vaccine in ...

Health Canada authorized Moderna's updated COVID-19 vaccine on Tuesday to roll out in fall immunization campaigns. The federal vaccine portal lists approval of Moderna's product. Provinces and ...

Moderna, Inc.'s combination flu and COVID-19 vaccine, mRNA-1083, showed strong Phase 3 results in adults over 50. Pfizer/BioNTech's combination vaccine faced setbacks, giving Moderna a potential ...

UCG / Contributor / Getty Images Moderna shares surged Tuesday after Canadian regulators approved the biotech firm’s updated COVID-19 vaccine. Moderna's Spikevax KP.2 targets the KP.2 variant of ...

Moderna stock is plunging Thursday after the COVID-19 vaccine maker announced plans to drastically cut its R&D spending to focus on new product approvals.

The two vaccines are Spikevax from Moderna and Comirnaty from Pfizer. When SBS News asked the Department of Health whether both vaccines would be available in 2024-25, its response suggested only ...

COVID-19 and the flu can ramp up during the fall. Health experts suggest getting an annual booster shot to prevent these illnesses. Staying up-to-date on vaccines can prevent more serious health ...

Moderna became a hero during the pandemic for its COVID-19 vaccine, Spikevax, but has faced difficulties in its aftermath. In 2020, the company was lauded for using new mRNA-based therapeutics ...